DHER34:BVMF
Danaher Corporation Bdr
R$38,47
0,00%
(0,00) 1D
15 Sep., 16:56:00 GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DHER34...
Open
R$38,35
High
R$38,47
Low
R$38,35
Mkt. cap
147,18Â mjd
Avg. vol.
2,36Â k
Volume
133,00
52-wk high
R$45,93
52-wk low
R$27,98
Shares outstanding
702,99Â m
No. of employees
59Â k
Open
R$38,35
High
R$38,47
Low
R$38,35
Mkt. cap
147,18Â mjd
Avg. vol.
2,36Â k
Volume
133,00
52-wk high
R$45,93
52-wk low
R$27,98
Shares outstanding
702,99Â m
No. of employees
59Â k
News stories
From web sources and news partners
GuruFocus
·
9 uur gelede
Danaher Corp (DHR) Shares Surge 3.0% -- What GF Score of 80 Tells Investors
Investing.com
·
9 uur gelede
Danaher declares $0.40 quarterly dividend
TradingKey
·
10 uur gelede
Danaher Corp Stock (DHR) Closed Up by 3.01% on Sep 15: A Full Analysis
TipRanks
·
1 dag gelede
Danaher Stock Slips As Sector Jitters Mount
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corporation Bdr